StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.71−0.90 (-6.61%)

Close on Nov 16, 2026Market cap $187.16MP/E –Yield –

Korro Bio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Korro Bio's profit margin for the twelve months ending Jun 30, 2026 was -4477.1%. For fiscal 2025 it was -1834.5%, against -3680.4% the year before. The highest annual figure on record is -64.8% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1834.5%+1845.9
FY2024Dec 31, 2024-3680.4%−3078.4
FY2021Dec 31, 2021-602.0%−530.3
FY2020Dec 31, 2020-71.7%−6.9
FY2019Dec 31, 2019-64.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-3873.2%−2939.8
Q3 FY2025Sep 30, 2025-1657.0%−1469.5
Q2 FY2025Jun 30, 2025-1765.1%−1327.0
Q1 FY2025Mar 31, 2025-917.1%−814.3
Q4 FY2024Dec 31, 2024-933.5%−886.0
Q2 FY2021Jun 30, 2021-187.5%−116.8
Q1 FY2021Mar 31, 2021-438.1%−370.4
Q4 FY2020Dec 31, 2020-102.8%+13.8
Q3 FY2020Sep 30, 2020-47.5%−45.1
Q2 FY2020Jun 30, 2020-70.7%–
Q1 FY2020Mar 31, 2020-67.6%–
Q4 FY2019Dec 31, 2019-116.6%–
Q3 FY2019Sep 30, 2019-2.4%–

More Korro Bio figures

See a number that looks wrong?